©2018 by GC Therapeutics. Proudly created with Wix.com

GC Therapeutics, Inc.

A Path to SuperCells™ Therapies

Our Technology

GCTx uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cell fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases. 


Who We Are

The core technology of GC Therapeutics Inc. (GCTx) was conceived, invented and perfected in Prof. George Church's lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.


Our Team

George Church, Ph.D.

Senior Advisor

Parastoo Khoshakhlagh, Ph.D.

Chief Executive Officer,


Alex Ng, Ph.D.

Chief Scientific Officer,



Kiavash Kiaee

Stem Cell Biologist

Mark Zaki

Medical Analyst

Khaled Said

Molecular Biologist


Press Release

We are hiring!

Contact us if you are as excited as we are!

  • Do you have experience in stem cell biology?

  • Do you have experience in synthetic biology?

  • Do you have experience in molecular biology?

"Engineering cell types is the key to cell therapies, transplants and testing new drugs"

George Church

Locks on a Bridge

Evan Appleton, Ph.D.

Machine Learning Fellow

Test Tubes

Synthetic biology researchers receive 2018 Massachusetts Life Science Innovation Day prize

July 2018

Award recognizes TFome platform technology that enables rapid engineering of a broad spectrum of tissue-specific cell types